Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C E Higham

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 16, 2015
Bone Health and Pelvic RadiotherapyC E Higham, S Faithfull
Experimental Physiology|July 12, 2008
Growth hormone excess and the development of growth hormone receptor antagonistsC E Higham, P J Trainer
The Journal of Endocrinology|June 5, 2015
60 YEARS OF NEUROENDOCRINOLOGY: The hypothalamo-GH axis: the past 60 yearsP G Murray, C E Higham, P E Clayton
Endocrinology, Diabetes & Metabolism Case Reports|June 5, 2014
Phaeochromocytoma and Acromegaly: a unifying diagnosisC Mumby, J R E Davis, J Trouillas, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|March 10, 2010
Licorice - or more?H Leitolf, K C S Dixit, C E Higham, et al.
FEBS Letters|March 21, 2000
Preparation of synthetic human islet amyloid polypeptide (IAPP) in a stable conformation to enable study of conversion to amyloid-like fibrilsC E Higham, E T Jaikaran, P E Fraser, et al.
The Journal of Clinical Endocrinology and Metabolism|April 16, 2009
Pegvisomant improves insulin sensitivity and reduces overnight free fatty acid concentrations in patients with acromegalyC E Higham, S Rowles, D Russell-Jones, et al.
Clinical Endocrinology|November 21, 2008
Long-term experience of pegvisomant therapy as a treatment for acromegalyC E Higham, T T Chung, J Lawrance, et al.
British Journal of Pharmacology|October 13, 2000
The antimalarial agent mefloquine inhibits ATP-sensitive K-channelsF M Gribble, T M Davis, C E Higham, et al.
European Journal of Endocrinology|May 5, 2009
Successful use of weekly pegvisomant administration in patients with acromegalyC E Higham, J D J Thomas, M Bidlingmaier, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 16, 2015
Bone Health and Pelvic RadiotherapyC E Higham, S Faithfull
Experimental Physiology|July 12, 2008
Growth hormone excess and the development of growth hormone receptor antagonistsC E Higham, P J Trainer
The Journal of Endocrinology|June 5, 2015
60 YEARS OF NEUROENDOCRINOLOGY: The hypothalamo-GH axis: the past 60 yearsP G Murray, C E Higham, P E Clayton
Endocrinology, Diabetes & Metabolism Case Reports|June 5, 2014
Phaeochromocytoma and Acromegaly: a unifying diagnosisC Mumby, J R E Davis, J Trouillas, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|March 10, 2010
Licorice - or more?H Leitolf, K C S Dixit, C E Higham, et al.
FEBS Letters|March 21, 2000
Preparation of synthetic human islet amyloid polypeptide (IAPP) in a stable conformation to enable study of conversion to amyloid-like fibrilsC E Higham, E T Jaikaran, P E Fraser, et al.
The Journal of Clinical Endocrinology and Metabolism|April 16, 2009
Pegvisomant improves insulin sensitivity and reduces overnight free fatty acid concentrations in patients with acromegalyC E Higham, S Rowles, D Russell-Jones, et al.
Clinical Endocrinology|November 21, 2008
Long-term experience of pegvisomant therapy as a treatment for acromegalyC E Higham, T T Chung, J Lawrance, et al.
British Journal of Pharmacology|October 13, 2000
The antimalarial agent mefloquine inhibits ATP-sensitive K-channelsF M Gribble, T M Davis, C E Higham, et al.
European Journal of Endocrinology|May 5, 2009
Successful use of weekly pegvisomant administration in patients with acromegalyC E Higham, J D J Thomas, M Bidlingmaier, et al.
Pageof 2